JP Nadda clears 100 MBBS seats for Kerala, reaffirms AIIMS push
Synopsis
Key Takeaways
Union Health Minister J.P. Nadda on Tuesday, 28 July gave in-principle approval for 100 MBBS seats at the K. Karunakaran Memorial Government Medical College in Thiruvananthapuram, effective from the next academic year, and reaffirmed the Centre's commitment to sanction an AIIMS for Kerala. The assurances were delivered during a high-level meeting in New Delhi with a Kerala delegation led by State Health Minister K. Muraleedharan.
The Medical College Delay
Nadda reportedly expressed sharp concern over the prolonged delay in commencing MBBS admissions at the K. Karunakaran Memorial Government Medical College, noting that infrastructure worth hundreds of crores had been in place for nearly a decade without a single student being enrolled. He described the delay as criminal negligence, observing that an estimated 1,100 students could have benefited from medical education had admissions begun on schedule. The in-principle clearance for 100 MBBS seats from the next academic year marks the first concrete step toward operationalising the long-dormant institution.
Key Healthcare Commitments
Beyond medical education, Nadda extended Central support across several critical areas. He asked Kerala to submit a formal proposal for establishing India's first Genetic Institute in the state — a move that would position Kerala at the frontier of genomic medicine. He also committed to setting up Trauma Care Centres in every district by strengthening existing district hospitals.
The Union Minister gave in-principle approval to Kerala's request for enhanced insurance coverage under the Centre's health insurance scheme and assured support for upgrading the state's three Mental Health Centres. Central assistance for administering the Human Papillomavirus (HPV) vaccine to girls was also promised, reflecting a push on preventive healthcare.
NHM Funding and Specialised Support
Kerala raised concerns over the adequacy of existing allocations under the National Health Mission (NHM), and Nadda said the Centre would consider increasing financial support after reviewing the state's submission. The Union Minister also agreed to enhance Central assistance for the State Virology Institute, acknowledging Kerala's established role in public health surveillance — a capacity that proved critical during successive outbreak responses in the state.
The Kerala delegation additionally sought help in ensuring availability of medicines for non-communicable diseases, select cancer drugs, and certain medicines not currently manufactured in India. Nadda assured that the matter would be examined and appropriate steps taken.
Political and Policy Context
According to Minister Muraleedharan, Nadda described the meeting as cordial and responded positively to the state's demands. This comes amid a broader Centre-state dynamic where Kerala has historically sought greater federal support for its relatively advanced but resource-stretched public health system. Notably, the state's push for an AIIMS has been pending for several years, and Tuesday's reaffirmation — while not a formal sanction — signals continued engagement at the ministerial level.
If the commitments translate into actionable timelines, Kerala's health sector stands to gain substantially, from expanded medical education capacity to specialised institutions that currently do not exist anywhere in the country.